(S)-(+)-4-[7-(2,2-Dimethyl-1-oxopro- poxy)-4-methyl-2-[4-[2-(1-piperidinyl)- ethoxy]phenyl]-2H-1-benzopyran-3-yl]- phenyl 2,2-Dimethylpropanoate (EM-800): A Highly Potent, Specific, and Orally Active Nonsteroidal Antiestrogen
- 1 July 1997
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (14), 2117-2122
- https://doi.org/10.1021/jm970095o
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- ICI 182,780, a new antioestrogen with clinical potentialThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Studies on the activation of the oestrogen receptor bound to the anti-oestrogens 4-hydroxytamoxifen and ICI 164,384 by using three monoclonal antibodiesJournal of Molecular Endocrinology, 1991
- Synthesis and biological activity of new halo-steroidal antiestrogensJournal of Medicinal Chemistry, 1991
- Structure-activity relationship of antiestrogens. Phenolic analogs of 2,3-diaryl-2H-1-benzopyransJournal of Medicinal Chemistry, 1990
- Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyransJournal of Medicinal Chemistry, 1990
- Biology and mode of action of pure antioestrogensJournal of Steroid Biochemistry, 1988
- The estrogenic and antiestrogenic activities of androgens in female target tissuesPharmacology & Therapeutics, 1983
- Establishment and characterization of a cell line of human breast carcinoma originEuropean Journal of Cancer (1965), 1979
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978